---
layout: minimal-medicine
title: Cytomegalovirus Immunoglobulin (CMV Ig)
---

# Cytomegalovirus Immunoglobulin (CMV Ig)
### Generic Name
Cytomegalovirus Immunoglobulin (CMV Ig)

### Usage
Cytomegalovirus immunoglobulin (CMV Ig) is a crucial medication used primarily to prevent cytomegalovirus (CMV) disease in individuals who have received organ transplants, such as kidney, lung, liver, pancreas, or heart transplants.  It's particularly important when a CMV-positive donor (carrying the CMV virus) provides an organ to a CMV-negative recipient (who lacks immunity to the virus).  In cases of liver, lung, pancreas, or heart transplants (excluding kidneys) from CMV-positive donors to CMV-negative recipients, CMV Ig is often used alongside ganciclovir for enhanced protection.  While less common, CMV Ig may also be used off-label in treating severe CMV pneumonitis in patients who have had hematopoietic stem cell transplants, again often in combination with ganciclovir.


### Dosage

**Adult Dosage (IV):**

* **Prophylaxis of CMV disease (Kidney transplant):**
    * Initial dose (within 72 hours of transplant): 150 mg/kg
    * Subsequent doses at 2, 4, 6, and 8 weeks post-transplant: 100 mg/kg
    * Doses at 12 and 16 weeks post-transplant: 50 mg/kg

* **Prophylaxis of CMV disease (Liver, Lung, Pancreas, or Heart transplant):**
    * Initial dose (within 72 hours of transplant): 150 mg/kg
    * Subsequent doses at 2, 4, 6, and 8 weeks post-transplant: 150 mg/kg
    * Doses at 12 and 16 weeks post-transplant: 100 mg/kg

* **Treatment of severe CMV pneumonitis (Off-label, with ganciclovir):**
    * 400 mg/kg on days 1, 2, and 7, followed by 200 mg/kg on day 14.  Additional doses of 200 mg/kg on day 21 or 150 mg/kg twice weekly may be considered if symptoms persist.

**Pediatric Dosage (IV):**  Note that antiviral medications are generally recommended for CMV prophylaxis in children. Dosage specifics vary greatly depending on the type of transplant, the child's risk level (based on donor/recipient CMV status), and the presence or absence of viremia (virus in the blood). Consult a physician or the prescribing information for precise dosing guidelines.  The general approach is similar to adult dosing, adjusted for the child's weight.


**Dosage Adjustments:** The manufacturer's labeling doesn't specify dosage adjustments for hepatic (liver) or renal (kidney) impairment.  However, caution is advised, especially in individuals with renal problems.  In such cases, the infusion rate should be kept as low as possible.

### Side Effects

**Common Side Effects (<6%):**

* Chills
* Flushing
* Nausea and vomiting
* Arthralgia (joint pain)
* Back pain
* Muscle cramps
* Wheezing
* Fever

**Less Common, but Serious Side Effects (<1%, from post-marketing data and case reports):**

* Abdominal pain
* Acute renal failure
* Acute respiratory distress
* Anaphylactic shock
* Angioedema
* Aseptic meningitis
* Bronchospasm
* Bullous dermatitis
* Circulatory shock
* Coma
* Cyanosis
* Decreased blood pressure
* Dyspnea (shortness of breath)
* Epidermolysis (skin blistering)
* Erythema multiforme
* Hemolysis (red blood cell destruction)
* Hepatic insufficiency (liver failure)
* Hypotension
* Hypoxemia (low blood oxygen)
* Leukopenia (low white blood cell count)
* Loss of consciousness
* Oliguria (decreased urine output)
* Osmotic nephrosis (kidney damage)
* Pancytopenia (low counts of all blood cells)
* Positive direct Coombs test (sign of immune-mediated hemolysis)
* Pulmonary edema (fluid in the lungs)
* Renal insufficiency (kidney failure)
* Renal tubular necrosis (kidney damage)
* Rigors (shaking chills)
* Seizures
* Stevens-Johnson syndrome (severe skin reaction)
* Thromboembolism (blood clot)
* Transfusion-related acute lung injury (TRALI)
* Tremor

**Important:**  If any adverse effects occur, seek immediate medical attention.

### How it Works

CMV Ig provides passive immunity against CMV. It contains high concentrations of antibodies (specifically IgG, with trace amounts of IgA and IgM) targeting the CMV virus.  By administering CMV Ig, the recipient receives a ready supply of these antibodies, helping to neutralize the virus and prevent it from causing disease. This reduces the risk of developing serious CMV-related complications, particularly in transplant recipients.

### Precautions

* **Contraindications:**  CMV Ig is contraindicated in individuals with hypersensitivity (allergy) to CMV Ig, other immunoglobulin preparations, or any component of the formulation; and those with selective IgA deficiency.
* **Increased Risk:**  There's an increased risk of anaphylaxis/hypersensitivity reactions, aseptic meningitis, pulmonary edema, thrombotic events, hemolysis, and acute renal dysfunction.
* **Cautious Use:** Use with caution in patients over 65 and those with renal impairment.
* **Drug Interactions:** Live vaccines may have reduced effectiveness when given concurrently with CMV Ig.  Avoid concurrent use.
* **Pregnancy and Lactation:** CMV Ig is categorized as pregnancy category C.  It's unknown whether it causes fetal harm or affects reproductive capacity.  Use only if clearly needed during pregnancy.  Excretion in breast milk is unknown.


### FAQs

* **Q: How is CMV Ig administered?** A: CMV Ig is given intravenously (IV) through an infusion pump and filter.  The infusion rate is carefully controlled to minimize adverse reactions.

* **Q: How long does it take to work?** A: The effects of CMV Ig are immediate, providing passive immunity.

* **Q: How is CMV Ig stored?** A: Store CMV Ig as per the manufacturer's instructions, usually under refrigeration.

* **Q: What should I do if I miss a dose?** A: Contact your doctor immediately to discuss how to proceed.

* **Q: Are there any long-term effects?** A:  Long-term effects are rare, but as with any medication, potential side effects should be monitored.

* **Q:  Is CMV Ig a cure for CMV?** A: No, CMV Ig is a prophylactic (preventative) treatment, not a cure. It reduces the risk of CMV disease but does not eliminate the virus.


**Disclaimer:** This information is intended for educational purposes only and does not provide medical advice. Always consult a healthcare professional for diagnosis and treatment of any medical condition.  The specific dosage and administration of CMV Ig should always be determined by a physician based on the individual patient's needs and medical history.
